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Abstract  
This paper describes the formation of a civil society consortium, spurred to action by frustration over the Ebola crises, to facilitate the development 
of infrastructure and frameworks including policy development to support a harmonized, African approach to health crises on the continent. The 
Global Emerging Pathogens Treatment Consortium, or GET, is an important example of how African academics, scientists, clinicians and civil 
society have come together to initiate policy research, multilevel advocacy and implementation of initiatives aimed at building African capacity for 
timely and effective mitigations strategies against emerging infectious and neglected pathogens, with a focus on biobanking and biosecurity. The 
consortium has been able to establish it self as a leading voice, drawing attention to scientific infrastructure gaps, the importance of cultural 
sensitivities, and the power of community engagement. The GET consortium demonstrates how civil society can work together, encourage 
government engagement and strengthen national and regional efforts to build capacity. 
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Introduction 
  
The 2014-2015 Ebola virus disease outbreak devastated an already 
weak public health infrastructure in West Africa. Ebola deaths 
amongst African healthcare workers only exacerbated the problem. 
The most affected nations had to rely on international response 
efforts to mitigate the consequences of the disease; a response that 
came many months too late. It became apparent that a unified, 
indigenous voice or coalition of African experts to assist with early 
detection, defining and coordinating the logistics of response on the 
ground was lacking. This paper describes the formation of a civil 
society consortium, spurred to action by frustration over the Ebola 
crises, to facilitate the development of infrastructure and 
frameworks including policy development to support a harmonized, 
African approach to health crises on the continent. The Global 
Emerging Pathogens Treatment Consortium, or GET, is an important 
example of how African academics, scientists, clinicians and civil 
society have come together to initiate policy research, multilevel 
advocacy and implementation of initiatives aimed at building African 
capacity for timely and effective mitigations strategies against 
emerging infectious and neglected pathogens. The GET consortium 
demonstrates how civil society can work together, encourage 
government engagement and strengthen national and regional 
efforts to build capacity consistent with the Global Health Security 
Agenda. 
  
Establishment of GET 
  
The GET consortium was established on the 21st of August 2014 
during the peak of the Ebola outbreak and soon after the index case 
arrived in Lagos, the 23 million population mega city and 
commercial capital of Nigeria. The consortium's, aim is to bring like-
minded and relevant experts together, who are working in Africa to 
provide indigenous capacity to collectively address an ever 
increasing menace of emerging and re-emerging dangerous 
infectious pathogens. As the Ebola outbreak unfolded in Lagos, it 
became apparent that an unexpected percentage of Ebola patients 
were surviving. The founding members of GET, amongst other 
initiatives, prioritized their mission to find an immediate, local 
solution to counter the spread of Ebola for which there is still no 
known treatment- particularly in a vulnerable mega city like Lagos. 
It was hypothesized based on very rudimentary evidence and 
animal studies, that if the outbreak was not contained, there were 
going to be an increasing number of survivors and possibly the only 
immediate solution was the use of passive immunity from survivors 
using convalescent plasma donations containing anti Ebola 
antibodies and transfused under stringent conditions to new cases 
[1,2]. This approach became a collaborative effort with international 
partners, aimed at building the regional capacity to harvest, process 
and submit convalescent plasma to clinical trials during the 
outbreak. This eventually led to the convalescent trial capacity drive 
in Liberia, Sierra Leone, Guinea and Nigeria, which is still on going. 
This was also accompanied by community outreach to survivors as 
well as developing guidelines and advice on the ethics of research 
during public health crises. To achieve the objectives of the 
convalescent approach, the founding GET consortium members 
reached out to their colleagues across the region, and in particular 
within Guinea, Sierra Leone and Liberia, to see how this 
convalescent plasma strategy could be accelerated. The recruitment 
drive through person to person contact and existing networks of 
related Africa consortia soon extended across the whole continent 
with enthusiastic response from professionals from a variety of 
disciplines offering of their time voluntarily. The network now 
includes experts from infectious diseases, pathology, bio-
informatics, bio-banking, ethics, social science, economics, patient 
advocacy, logistics, engineers, ecologists, government 
administrators, creating artist and several other disciplines. A 
temporary governance structure was developed and officers 
appointed. The consortium was registered in Nigeria, Ghana and the 
United States. The GET consortium ultimately intends to register a 
presence in every African country as well as in major hubs 
internationally to ensure that the consortium taps into the wider 
African Diaspora, while also reaching out to international scientists 
and supporters who have an interest in capacity development on 
the African Continent. Through initial institutional funding provided 
by the Bill and Melinda Gates foundation, GET was able to sustain 
its growth and develop into a fully functional Civil Society 
Organization aimed at public health policy research and 
implementation with expanding impact across several sectors of 
medicine, logistics and the social sciences. Once GET was formally 
established, the consortium identified a series of priority issues and 
proposals for immediate action. These priority issues were driven by 
the fragmented response to the Ebola outbreak, which appeared to 
lack sensitivity to the cultural and indigenous knowledge based 
systems of the continent. This resulted in the formation of nine 
policy and operational working groups (Figure 1). These include: 
Ethics, Community Engagement, Patient Advocacy, and Support 
(ECEPAS); Research and Clinical Trials; Plasmapheresis; Grant, 
Proposal and Publications; Bio-banking, bio-data, bio-safety, 
biosecurity, bioinformatics (B5); Cultural, Anthropological, Social and 
Economic Impact (CASE); HIV cure; Climate, Environmental and 
Disease Surveillance and bio-intelligence (CESI); Media and 
Communication. Through the executive committee and the working 
groups, the GET consortium has been able to move rapidly to 
organized academic partners, governments, international 
organizations and associated partners. 
  
Results 
  
In a relatively short period of time, the civil society consortium has 
been able to forge new partnerships, establish regional positions, 
and facilitate commitments by governments. Table 1 depicts some 
of the GET organized events, proposals, and workshops. In 
collaboration with West African regional partners, GET was 
instrumental in organizing the first African Voices and Leadership 
conference on Ebola held in Dakar in January 2015. The meeting 
brought together representatives from leading regional and 
continental health authorities (including the United Nations, World 
Food Programme, World Health Organization, African Union, MSF, 
ECOWAS, WAHO, NEPAD, and MSF), representatives of the 
ministries of health of the ECOWAS region, scientists, Ebola 
survivors and Ebola treatment center health care givers. During this 
meeting the multitude of socio-economic, infrastructural and 
capacity deficiencies that permitted the Ebola outbreak to affect so 
many, were identified and crystalized into what became the Dakar 
Declaration [3]. This meeting clearly defined key infrastructure 
deficiencies, such as biobanking facilities and biosecurity 
infrastructures, and the lack of a framework to address the stigma, 
rehabilitation and care of Ebola survivors. The necessary policies 
that would govern such infrastructure development and frameworks 
required urgent attention. GET has facilitated a series of meetings 
to explore hosting a conference focused on biobanking and 
biosecurity infrastructure, and has worked to establish African 
infrastructure to conduct plasmapheresis and plasma storage 
facilities in key strategic locations in Africa to support Ebola clinical 
trials. The success of GET can also be demonstrated in the 
consortium's interventions in Sierra Leone. GET has provided 
templates and expertise in fair contract negotiations for clinical trials 
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agreements to ensure intellectual property rights are maintained for 
the Ebola affected countries. GET also led the drive to ensure the 
Ebola affected countries were aware of the biosecurity and biosafety 
threats posed by Ebola samples, given the insecure environments of 
the current laboratory systems, and provided options to take 
ownership and control of the samples. The samples left over from 
the 2014/15 Ebola outbreak were strewn throughout partner labs 
that were set up all over the subregion. However some of these labs 
have shut down. More are due to do so, and there is as yet no 
agreed process regulating safe handing over or disposal of 
dangerous substances. These remaining samples of Ebola are left 
without the requisite conventional security to prevent their 
accidental discharge or intentional theft for unregulated research or 
possible non-peaceful activities. GET has been entrusted with raising 
the Government awareness on biobanking, drafting a national 
policy, and crafting the road map for data rescue of the samples 
belonging to Sierra Leone with a view to having a safe and 
sustainable biobank GET used established networks to access the 
membership of relevant African Societies and established academic 
research networks such as the H3Africa and B3Africa consortia to 
build upon established guidelines for sample and data management 
as the basis for formulating standard operating practices in the 
Ebola affected countries. These examples illustrate how increased 
technical expertise, as promoted and shared by GET, enabled south-
south collaboration. In addition to these activities organized or 
supported by GET, the consortium has improved its regional and 
global recognition as a representative voice committed to improving 
infrastructure and capacity to cope with public health crises caused 
by epidemics in Africa. Part of this recognition has been the 
consistent invitations to participate in and speak at regional, 
international conferences and policy forums, becoming an important 
voice in policy discussions around global health security, biosafety, 
biosecurity, biobanking and ethics. GET is building up a number of 
reports and manuscripts that document its experience on this 
trajectory and these can be found on its website [4]. 
  
Discussion 
  
The GET consortium has been able to establish itself as a leading 
voice, drawing attention to scientific infrastructure gaps, the 
importance of cultural sensitivities, and the power of community 
engagement. These efforts are vital to the core mission of the 
Global Health Security Agenda- making the world safer from 
infectious disease threats. The GET consortium is working to build 
African capacity to detect, respond and recover from infectious 
diseases, and doing so through their ability to harness the training, 
passion and capacity of African medical and non-medical 
professionals. The GET consortium can be a model for all regions of 
the world, demonstrating that committed civil society can engage in 
the hardest problems of their region in support of governments and 
populations. The consortium, however, has faced multiple 
challenges. Potential research collaborators have questioned the 
strength of the consortium, and even questioned the possibility of 
African professionals to desire to come together as they have under 
GET, complicating fund raising efforts. GET realizes that it should 
also turn its attention to indigenous funding streams including 
corporate social responsibility to accelerate the African bio-
economy. There are many health related challenges across the 
African continent due to endemic burden of disease and a multitude 
of environmental and host factors that facilitate the emergence of 
biological threats. These health challenges are amplified by an 
insufficient clinical workforce, infrastructure challenges, strained 
governments, and limited resources. In the midst of this challenging 
environment, the GET consortium has emerged as a means for 
African civil society to work together to support improved health 
outcomes, strengthen global health security, and build much needed 
capacity to combat biological threats. 
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Table 1:  GET activities 
Name Date Outcome 
Ethics, Community Engagement and 
Ebola Survivor Advocacy and Support 
October 2014 Ethical review of protocol for first ever convalescent trial in Liberia 
Lagos State Ministry of Health October 2014 Through an MOU with the Lagos State Government Ministry of Health, GET has supported the Ebola 
Core Research group formed in Lagos 
Logistical support for ClinicalRM November 2014 Logistics for massive air drop of blood mobiles, apheresis machines and medical supplies to Guinea 
Liberia and Nigeria 
Biobanking Proposal January  2015 First indigenous initiative proposal for a comprehensive attempt to secure all Ebola samples in the 
region and develop biobanking and biosafety facilities and frameworks presented to the Global 
Partnership 
First African Voices and Leadership 
Conference on Ebola and EID 
January 2015, Senegal Dakar Declaration: Lack of biobanking and biosecurity capacity and frameworks is contributing 
factor to rapid spread of West African Ebola outbreak 
Ebola Survivor Workshop with Ebola 
Survivors Association of Liberia (ESAL) 
January 2015,  Liberia Growth of 500 to 800 survivors registered with ESAL 
Ebola Survivor Workshop with Sierra 
Leone Association of Ebola Survivors 
(SLAES) 
February, 2015 Freetown, 
Sierra Leone. 
Building network of Ebola survivors and infrastructure. Piloted creative fine art as a means of 
healing Post Traumatic Stress Disorder experienced by survivors. 
Knowledge, Attitude and Perception 
Study 
February 2015, Sierra Leone Introduced new study to attempt to understand factors in community that generate discrimination 
against Ebola survivors. 
Engagement with NOGUCHI BSL 3 
Facility 
August 2015, Accra, Ghana Development of Memorandum of Understanding for support to the most affected countries. 
1st WHO meeting on Ebola and 
Biobanking 
May 2015, Geneva, 
Switzerland 
GET represented at first WHO meeting on Ebola and biobanking . Agreed that an accelerated 
approach to biobanking was required with more indigenous representation to be scheduled in the 
West African region. 
2nd  WHO meeting on Ebola survivors 
and Biobanking 
August 2015 Freetown, 
Sierra Leone, 
A continuation of the discussion initiated in Geneva with a more focused approach on indigenous 
solutions. This was immediately followed by a GET workshop on Biobanking and Biosecurity 
National biobanking and biosecurity 
policy workshop in Sierra Leone 
August 2015 Freetown, 
Sierra Leone 
First indigenous workshop on biobanking and biosecurity, aimed at supporting the Government of 
Sierra Leone to develop its national biobanking and biosecurity framework. 
West African Task force for the research 
into Emerging and re-emerging 
Infections (WATER). 
August 2015 
Sierra Leone 
Founding members of GET and representatives of WATER agreed to synchronize activities in the 
West African Region, to ensure elimination of duplicity and ensure effective use of resources and 
human capacity.  
MSF-GET August 2015 
Sierra Leone 
Series of meeting between GET and MSF culminated in a strategic approach to coordinate and 
support the efforts of GET and WATER to accelerate biobanking and biosecurity capacity in Africa 
African Gong August 2015 
Cape Town,  South Africa 
Founding members of African Gong and GET met to map out the modalities of hosting the first 
African Conference on Science Communication and Public understanding of science. 
WHO Ethics meeting September 2015 Cape 
Town, South Africa 
GET PI gave a summary of the second WHO meeting held in Freetown, aimed at further refining 
guidelines for the ethical approach to public health emergencies based on lessons learned during 
the Ebola outbreak.  
Trends Symposium to support the 
Biological Weapons Convention 
September 2015 
Poland 
GET Principal Investigator was requested to give an overview of the biosecurity issues in the Ebola 
affected region and how new technology has made a difference. 
Royal College of Pathologists of the 
United Kingdom (RCPath) 
September 2015 
Kampala, Uganda 
  
GET and senior members of the International Division of the Royal College of Pathology, met at the 
Labskills Africa conference to map out  future collaborations 
Global Health Security Agenda (GHSA) 
meeting organized by the African 
Society of Laboratory Medicine (ASLM). 
October 2015. Freetown, 
Sierra Leone. 
GET members invited, participated in this meeting contributing to improved understanding of the 
biosecurity deficits in the region.  
Africa Union Peace and Security 
Department. Consultative meeting on 
the Universalization of the Biological 
Weapons Convention (BWC) in Africa. 
October 2015. Addis, 
Ethiopia 
GET was invited as a speaker and observer to share experiences in the containment strategies of 
the Ebola Outbreak and contributions towards capacity building for enhanced implementation of the 
BWC. 
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Figure 1: GET organizational structure 
 
 
 
 
 
